In July 2011, the FDA approved expanding the age indication for Boostrix® (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed) to ≥65 years of age and in February 2012, ACIP recommended Tdap for all adults ≥65 years of age.
Tdap products in adults aged 65 years and older. When feasible, Boostrix should be used for adults aged 65 years and older; however, ACIP concluded that either vaccine administered to a person 65 years or older is immunogenic and would provide protection. A dose of either vaccine may be considered valid.
October 28, 2010 — The Centers for Disease Control and Prevention’s (CDC’s) Advisory Committee in Immunization Practices (ACIP) has recommended a booster dose of the tetanus, diphtheria, and pertussis (Tdap) vaccine in people between the ages of 11 and 64 years and in those older than 65 years if they come in close
When feasible, give Boostrix to adults age 65 and older. However, either vaccine product (Adacel or Boostrix) provides protection and is considered valid for use in people in this age group. For adults not previously vaccinated with Tdap who need wound management care to prevent tetanus, Tdap is preferred over Td.
Every adult should get a Tdap vaccine once if they did not receive it as an adolescent to protect against pertussis (whooping cough), and then a Td (tetanus, diphtheria) or Tdap booster shot every 10 years.
DTaP is approved for children under age 7. Tdap, which has a reduced dose of the diphtheria and pertussis vaccines, is approved for adolescents starting at age 11 and adults ages 19 to 64. It is often called a booster dose because it boosts the immunity that wanes from vaccines given at ages 4 to 6.
The biggest difference is the age that the vaccines are recommended for. While Adacel is indicated for patients 10-64 years old, Boostrix is indicated for patients 10 years of age and older. Currently, Boostrix is the only Tdap vaccine indicated in patients 65 years of age and older!
This should be followed by either a Td or Tdap booster every 10 years. (Note: When feasible, Boostrix® should be used for adults 65 years or older; however, either vaccine product administered to a person 65 years or older is valid.
A booster dose is recommended every 10 years. There are four reduced antigen content (dTpa) formulations registered in Australia, including two in combination with IPV: Boostrix® (dTpa), Boostrix®-IPV (dTpa-IPV), Adacel® (dTpa) and Adacel® Polio (dTpa- IPV).
Three common but potentially dangerous diseases that older people should be vaccinated against are influenza, pneumococcal disease and shingles (herpes zoster). Booster vaccinations against tetanus, diphtheria and whooping cough are also recommended for older people.
5 Vaccines Recommended for Adults Age 65 and Older
Studies estimate that diphtheria toxoid-containing vaccines protect nearly all people (95 in 100) for approximately 10 years. Protection decreases over time, so adults need to get a Td or Tdap booster shot every 10 years to stay protected.
ALL adults who did not get Tdap vaccine as an adolescent should get one dose of this vaccine. Once they have had this dose, a Td or Tdap booster shot should be given every 10 years.
This article is in your queue. Why don’t Covid-19 vaccinations last longer? Measles shots are good for life, chickenpox immunizations protect for 10 to 20 years, and tetanus jabs last a decade or more.
The good news is that you can protect yourself against many of these diseases with a simple vaccination. Common diseases you can protect yourself against are tetanus, diphtheria, influenza, pneumococcal disease, whooping cough and shingles.
The most important vaccinations seniors should discuss with their physicians include the flu vaccine, pneumococcal vaccine to prevent pneumonia, shingles vaccine, and a tetanus-diptheria-pertussis vaccine (Tdap).